MedAdvisor Limited (ASX: MDR) Webcast Replay
5th April, 2023
MedAdvisor Limited (ASX: MDR) is an Australian medtech and global leader in medication management solutions with a global network of nearly 38,000 pharmacies reaching 235 million patients
As a part of our ‘The Insiders: Meet the CEOs’ series, CEO Rick Ratliff, provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 5th April 2023 at 12pm (AEST).
Join the next The Insider: Meet the CEOs webcast
FEATURED SPEAKER
RICK RATLIFF
CEO - MedAdvisor Limited (ASX: MDR)
MedAdvisor provides simple medication communication solutions to improve patients’ awareness and understanding of their medications. The company’s mobile app, pharmacy software and patient engagement solutions encompass a comprehensive medication adherence platform addressing a US$600 billion problem. In H1 FY23, MedAdvisor earned $64.1 million and posted a record positive EBITDA of $8.6 million (up $13.1 million on H1 FY22). Operating within a total addressable market of US$16 billion (as at March 2023), the company aims to leverage its digital capabilities and accelerate expansion further into the global market.
